The Biolocity Oversight Committee serves as both an advisory council and decision-making board to select funded projects. The committee consists of clinical, industry, regulatory, investment, and entrepreneurial veterans with relevant technology and medical expertise, along with partner university technology transfer advisers.
Ibraheem Badejo, PhDSenior Director, New Ventures at Johnson & Johnson Innovation, Boston
Mark Boden, PhD
Senior Fellow/Technology Scout, Boston Scientific Corporation
Terry Bray, PhD
Director of Technology Licensing at Georgia Tech Research Corporation
Elias Caro, MSc
VP Technology Development at Wallace H. Coulter Foundation
Monte Eaves, MD
Professor of Surgery and Medical Director, Emory Aesthetic Center, Emory University School of Medicine
Andrés J. García, PhD
Executive Director, Parker H. Petit Institute for Bioengineering and Bioscience
Lee Herron, DVM
Vice President of Commercialization, Georgia Research Alliance
Michelle Ho, PhD
Analyst, 5AM Ventures
Susan Margulies, PhD
Chair of the Wallace H. Coulter Department, Georgia Research Alliance Eminent Scholar in Injury Biomechanics
Cliff Michaels, PhD, CLP, RTTP
Interim Executive Director, Office of Technology Transfer, Emory University
Rifat Pamukcu, MD
President & CEO, Midway Pharmaceuticals Inc.
Shyam Parekh, PhD, MBA
Director, Strategy and Business Development, Avanos Medical
Jay Parrish, PhD
Chief Business Officer, Vir Biosciences & Arch Ventures
Donna See, MBA, MPH
Chief Business Officer, TARA Biosystems
Robert Taylor, MD
Professor of Medicine, Director, Division of Cardiology, Emory University School of Medicine
Robert Towarnicki, MS
Managing Partner, New Hope BioConsulting LLC
David Wright, MD
Associate Professor and Director, Emergency Neurosciences at Emory University School of Medicine
Bob Yoder, MBA
Senior Vice President and Chief Business Officer, Trevena, Inc.
Ajit Yoganathan, PhD
Associate Chair for Research, Wallace H. Coulter School of Biomedical Engineering
